A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...
A major study validates the GOLDEN model as an accurate tool for predicting HBsAg loss in interferon-treated chronic ...
SAN FRANCISCO -- A company hoping to market an inhalable formulation of interferon beta for viral lung diseases isn't dissuaded by phase III trial results in 623 hospitalized COVID-19 patients, which ...
Interferon-Free Treatment: No Longer a Dream? Several studies were presented at both Digestive Disease Week (DDW) 2012 in May and at the European Association for the Study of the Liver (EASL) annual ...
Annals of Nutrition & Metabolism, Vol. 71, No. 1/2 (2017), pp. 8-9 (2 pages) Kuloglu Z, Kansu A, Demirçeken F, Arici ZS, Berberoğlu M, Ocal G, et al: The influence of interferon-alpha and combination ...
The Covid-19 pandemic is characterized by successive waves of infection driven by variants that have evolved to become more transmissible and immune evasive. Much of the attention has focused on ...
Objective: To evaluate the cost effectiveness of subcutaneous interferon-ß-1a (IFNß-1a) 44µg three times weekly in relapsing-remitting multiple sclerosis (RRMS) using an econometric model. Methods: ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 76, No. 10 (Oct., 1979), pp. 4778-4782 (5 pages) Among the mediators of interferon action are one enzyme that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback